Roche officials said last week that price competition and lower reimbursement rates are forcing it to make an unspecified number of cuts in its U.S. sales force and at its research and development hubs in Indianapolis and Germany.
More money, mentoring would add fuel to lively industry.
An initiative is matching tech entrepreneurs with hospital officials in the hope of solving health care problems.
Eli Lilly and Co. shares rose nearly 5 percent Monday morning after it said a study found that its experimental stomach-cancer drug helped patients with advanced disease live longer.
Ron Thieme, who took over as president and CEO of AIT Laboratories during a management shakeup earlier this year, is leaving the company, the Indianapolis-based firm announced Monday morning.
Eli Lilly and Co. is betting on a “broad” range of diabetes products including pills, insulins and a once-a-week treatment to take on bigger competitors, said Enrique Conterno, president of Lilly Diabetes.
Indianapolis Business Journal convened a panel of experts at its Health Care & Benefits Power Breakfast on Sept. 28 to talk about industry issues including Medicaid, on-site health clinics and narrow networks. Panelists included Robert J. Brody, president and CEO of Franciscan St. Francis Health; Michael N. Heaton, partner, Katz Sapper & Miller; Dr. Gregory N. Larkin, commissioner, Indiana State Department of Health; Vicki F. Perry, president, CEO, Advantage Health Solutions Inc.; Dr. Ram Yeleti, president, Community Physician Network. The following is the unedited transcript of the discussion.
The unsuccessful lawsuit filed by a subsidiary of Belgium-based Bayer Bioscience claimed that insect-resistant corn products from affiliates of Dow AgroSciences violated two of its patents.
A coalition of vegetable growers and food producers led by Indiana-based Red Gold Inc. will ease off their opposition to a new herbicide developed by Indianapolis-based Dow AgroSciences LLC.
A $100 million neuroscience center Indiana University officials say will offer a "one stop shop" for patients recovering from head and spinal injuries, strokes and other medical conditions is days away from opening its doors in Indianapolis.
Massachusetts-based Hologic Inc., the company that bought Suros Surgical Systems Inc., will phase out its facility in Zionsville, bringing an end to 200 local jobs.
Cook Medical Inc. had been planning to open five new manufacturing plants over the next five years in small communities around the Midwest, including Indiana, but has shelved those plans because of the hit it will take from a new U.S. tax on medical devices.
Life sciences leaders discuss topics ranging from accomplishments to initial public offerings and the nature of innovation at the July 25 event.
The Indianapolis-based division of Dow Chemical Co. posted record second quarter sales of $1.7 billion, up 12 percent from the year-ago period, due to a small increase in prices and the introduction of new products.
Group sees role in cellular therapy as growth area with profit margins higher than core business.
Research and development comes under pressure in an age of austerity.
With spending running well ahead of revenue, West Lafayette-based Bioanalytical Systems Inc. ousts its CEO in favor of its CFO.
A new report shows Indiana’s life sciences companies performed better than their peers around the country—and far better than the rest of Indiana’s private sector—during the early phases of the economic downturn.
The skies got a little brighter for the orthopedic industry on Friday after Warsaw-based Biomet Inc. reported strong quarterly sales growth of 3.4 percent. That news sparked a small surge in the stock prices of two other Warsaw-based orthopedics companies.
Republicans in the U.S. House joined with 37 Democrats to pass a bill repealing a medical-device tax, chipping away at the 2010 health-care law in a victory for companies including Indiana-based Zimmer Holdings Inc. and Boston Scientific Corp.
